Anti-Angiopoietin Therapy with Trebananib for Recurrent Ovarian Cancer (TRINOVA-1): A Randomised, Multicentre, Double-Blind, Placebo-Controlled Phase 3 Trial

Monk, B. J.; Poveda, A.; Vergote, I.; Raspagliesi, F.; Fujiwara, K.; Bae, D. -S; Oaknin, A.; Ray-Coquard, I.; Provencher, D. M.; Karlan, B. Y.; Lhommé, C.; Richardson, G.; Rincón, D. G.; Coleman, R. L.; Herzog, T. J.; Marth, C.; Brize, A.; Fabbro, M.; Redondo, A.; Bamias, A.; Tassoudji, M.; Navale, L.; Warner, D. J.; Oza, A. M.

Anti-Angiopoietin Therapy with Trebananib for Recurrent Ovarian Cancer (TRINOVA-1): A Randomised, Multicentre, Double-Blind, Placebo-Controlled Phase 3 Trial

Authors

Monk, B. J.

Poveda, A.

Vergote, I.

Raspagliesi, F.

Fujiwara, K.

Bae, D. -S

Oaknin, A.

Ray-Coquard, I.

Provencher, D. M.

Karlan, B. Y.

Show 10 more

Issue Date

2014

Type

Journal Article

Citation

Monk, B. J.; Poveda, A.; Vergote, I.; Raspagliesi, F.; Fujiwara, K.; Bae, D. -S, et al. (2014). Anti-Angiopoietin Therapy with Trebananib for Recurrent Ovarian Cancer (TRINOVA-1): A Randomised, Multicentre, Double-Blind, Placebo-Controlled Phase 3 Trial. Obstetrical and Gynecological Survey, November 2014, 69(11):661-662. doi: http://dx.doi.org/10.1097/01.ogx.0000458794.60509.a8

URI

http://hdl.handle.net/10504/85872

ISSN

00297828

Collections

Faculty Bibliography Database

Full item page

Anti-Angiopoietin Therapy with Trebananib for Recurrent Ovarian Cancer (TRINOVA-1): A Randomised, Multicentre, Double-Blind, Placebo-Controlled Phase 3 Trial

Authors

Issue Date

Type

Language

Keywords

Research Projects

Organizational Units

Journal Issue

Alternative Title

Abstract

Description

Citation

Publisher

License

Journal

Volume

Issue

URI

PubMed ID

DOI

ISSN

EISSN

Collections